Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Anish Patel currently holds 263,311 shares of Enliven Therapeutics, Inc. (ELVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anish Patel has been a net seller of ELVN stock. They have purchased $0 and sold $3.0M worth of shares.
Anish Patel's most recent insider trade was on Dec 8, 2025, when they sold 1,705 shares at $21.78 per share.
Anish Patel serves as Executive at Enliven Therapeutics, Inc. (ELVN). They have executed 39 insider transactions totaling $3.0M over their tenure at the company.
Anish Patel holds the position of Executive at Enliven Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Anish Patel has shown a selling trading pattern, with $0 in total purchases and $3.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Anish Patel was on Jul 15, 2024, when they sold $776.0K worth of ELVN shares. This transaction involved 30,978 shares at $25.05 per share.
Anish Patel currently owns 263,311 shares of Enliven Therapeutics, Inc. (ELVN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Anish Patel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Anish Patel has 39 Form 4 filings on record as an insider at Enliven Therapeutics, Inc..
Set alerts for Anish Patel and 40,000+ other insiders.